September 12, 2011
MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
Cancer Center Seminar Series: Issues in the Use of Omics-Based Predictors in Clinical Trials –Notes from an NCI Workshop
Dr. Mark Schluchter, our Associate Director for Biostatistics, has been developing approaches and models for biomarker based clinical investigation. He attended the NCI workshop on this topic this summer, and will report on the consensus issues and recommendations that came from the conference. As a Cancer Center, we identified Biomarker informed clinical trials as our approach to personalized medicine in cancer investigation, with a goal of identifying appropriate treatments for specific patients. Mark will review the complexity of these issues, lessons learned and advise us how to do this better.
Please participate in this week's Cancer Center Seminar, Friday, September 16 at 12 pm in BRB 105.
NCI Provocative Questions: New RFAs
NCI recently released two RFAs that follow on the effort of Harold Varmus to engage us all in novel thinking about persistent questions in cancer. Many of you have an exciting and provocative response to the 24 major questions that made the cut. Topics include obesity, aging, detection, pathways, etc. Please see the full list in the RFAs: RFA-CA-11-011.html (R01) and RFA-CA-11-012.html (R21).
I would think that 40 applications from the Case Comprehensive Cancer Center would be competitive for the 20 4-year awards.
International Conference of the Society of Integrative Oncology (SIO)
Please participate in the Society of Integrative Oncology meeting November 10-12 in Cleveland.
We have worked hard to bring the Society of Integrative Oncology to Cleveland and their message is quite focused: providing complementary and fully integrated supportive oncology to practitioners and patients. Where successful, the approach really adds value to patients physicians and hospitals. The conference will provide new information on practical experience with supportive oncology measures, traditional medicine, balancing supplements with cancer treatment and cancer care, and methods to boost the immune response to cancer. I think there is a considerable amount to be learned by physicians, support staff, nurses and support specialists.
Please make an effort to register and attend.
CASE CCC IN THE NEWS
'Unrealistic Optimism' Poses Ethical Challenges, May Affect Informed Consent Process
Ohio Third Frontier Commission Awards Imaging Research
Projects led by Drs. Raymond Muzic and David Wilson and were awarded funding by the Ohio Third Frontier Commission:
Positron Mammographic Imaging: Raymond Muzic, PhD (project leader), Donna Plecha, MD, James O'Donnell, MD, Peter Faulhaber; Piotr Maniawski
These grants fund two significant imaging research projects that are part of the Philips Healthcare Global Advanced Imaging Innovation Center, a collaboration among CWRU, UH, and Philips Healthcare.
Case CCC Strategic Plan
All members should have recently received a draft of the Case CCC Strategic Plan for 2012-2018. This plan represents the efforts and discussion of the entire membership, Program Leaders, Executive Committee, and institutional leaders. It will be the basis for our renewal application and for institutional commitments for the coming six years.
Thoughts on gaps, and critical perspectives and needs are greatly appreciated. You may send any comments directly to Dr. Stan Gerson at firstname.lastname@example.org. All feedback will be discussed by the Executive Committee.
If you would like a copy of the Strategic Plan, please email Gillian Todd at email@example.com.
Mandatory Research Staff Continuing Education Sessions
Research Staff Continuing Education Sessions
These continuing education sessions are mandatory for all SCC and TCI research staff and is open to staff from other departments and institutes conducting clinical trials in oncology. Topics will cover an overview of the Case Comprehensive Cancer Center, updates and Standard Operating Procedures. Break-out sessions will cover the joint site initiation visit during from several perspectives such as regulatory, nursing, data management and quality assurance.
Please direct any questions to Melissa Kadar, Director of UH/SCC Clinical Trials at melissa.kadar@UHhospitals.org or 216-286-6639.
CTSC Nutrition Obesity Research Pilot Funding
New Investigators at CWRU are invited to submit applications for pilot projects for potential inclusion in the Nutrition Obesity Research Center Application. Successful proposals will be included in the NIDDK NORC Application and will be considered for funding beginning November 2011. For the purpose of this RFP, new investigators are those without current or prior NIH research project support (R01, P01, R24) as a PD/PI. Preference will be given to translational research proposals directed at important questions of Nutrition and Obesity.
Deadline: September 30
Peer Reviewed Cancer Research Program Discovery Award
Applications for the Peer Reviewed Cancer Research Program (PRCRP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program for the Discovery Award. The purpose of this award is to support innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods. Studies supported by this award are expected to develop robust preliminary data that will lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Pre-Application Deadline: October 13
Oncology Nursing Society Excellence in Oncology Nursing Health Policy and Advocacy Award
The Oncology Nursing Society is currently accepting applications for the Oncology Nursing Health Policy and Advocacy Award. The purpose of this award is to recognize and support achievements and involvement in oncology nursing health policy and advocacy.
Nomination Deadline: October 31
Robert Wood Johnson Foundation Health Policy Fellows
The Robert Wood Johnson Foundation Health Policy Fellows program provides the nation's most comprehensive fellowship experience at the nexus of health science, policy and politics in Washington, D.C. It is an outstanding opportunity for exceptional midcareer health professionals and behavioral and social scientists with an interest in health and health care policy. Fellows participate in the policy process at the federal level and use that leadership experience to improve health, health care, and health policy.
Deadline: November 9
NCI Provocative Questions Project
NCI's Provocative Questions Project is seeking applications from researchers eager to influence the state of cancer research by tackling potentially game-changing scientific questions that could drive progress against cancer. The grants will support research projects that use sound and innovative research strategies to solve specific problems and paradoxes in cancer research.
A total of 24 provocative questions posed during the nationwide Provocative Questions workshops and from website submissions have been selected for inclusion in the RFAs, "Research Answers to NCI's Provocative Questions": RFA-CA-11-011.html (R01) and RFA-CA-11-012.html (R21).
Deadline: November 14
NCI CANCER BULLETIN
September 6, 2011
**All events are open to anyone interested in attending
Pathology Research Seminar Series
Cancer Biology Seminar
Leaders in AIDS Research Seminar
Hematology and Oncology Division Research Conference
NCRM Lunch and Learn
NCRM Monthly Seminar
TGFβ Focus Group Meeting
Hematology/Oncology Fellows Conference
Taussig Cancer Institute Grand Rounds
Cancer Center Seminar Series
Cancer Center Research in Progress
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Graft Versus Host Disease Conference
ADDITIONAL UPCOMING SEMINARS & EVENTS
First Ascoli Piceno Conference on Gene Vaccination in Cancer
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
Lustgarten Foundation Innovator Awards Program- Basic Research
AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.